Glaukos (GKOS) Capital Expenditures Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.57% |
| Dec 31, 2025 | 40.77% |
| Sep 30, 2025 | -62.28% |
| Jun 30, 2025 | 42.64% |
| Mar 31, 2025 | -8.48% |
| Dec 31, 2024 | 7.74% |
| Sep 30, 2024 | 7.56% |
| Jun 30, 2024 | 2.80% |
| Mar 31, 2024 | 8.26% |
| Dec 31, 2023 | -17.57% |
| Sep 30, 2023 | -71.95% |
| Jun 30, 2023 | 49.97% |
| Mar 31, 2023 | 40.85% |
| Dec 31, 2022 | -63.88% |
| Sep 30, 2022 | 20.45% |
| Jun 30, 2022 | 48.29% |
| Mar 31, 2022 | 54.10% |
| Dec 31, 2021 | 86.07% |
| Sep 30, 2021 | -60.70% |
| Jun 30, 2021 | 96.54% |
| Mar 31, 2021 | 59.14% |
| Dec 31, 2020 | 41.74% |
| Sep 30, 2020 | 47.58% |
| Dec 31, 2019 | 32.62% |
| Sep 30, 2019 | 30.31% |